Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations.

Literature DB >> 28674473

Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations.

Abstract

This article, the second in a series of three, provides an overview of the efficacy and safety of cancer immunotherapies ranging from monoclonal antibodies to vaccines, including additional clinical considerations regarding immune checkpoint blockers.

Entities: Disease

Year: 2017 PMID： 28674473 PMCID： PMC5481296

Source DB: PubMed Journal: P T ISSN： 1052-1372

46 in total

1. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

Authors: David A Jacobsohn; Brenda F Kurland; Joseph Pidala; Yoshihiro Inamoto; Xiaoyu Chai; Jeanne M Palmer; Sally Arai; Mukta Arora; Madan Jagasia; Corey Cutler; Daniel Weisdorf; Paul J Martin; Steven Z Pavletic; Georgia Vogelsang; Stephanie J Lee; Mary E D Flowers
Journal: Blood Date: 2012-07-06 Impact factor: 22.113

2. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Authors: Jan J Cornelissen; Wim L J van Putten; Leo F Verdonck; Matthias Theobald; Emanuel Jacky; Simon M G Daenen; Marinus van Marwijk Kooy; Pierre Wijermans; Harry Schouten; Peter C Huijgens; Hans van der Lelie; Martin Fey; Augustin Ferrant; Johan Maertens; Alois Gratwohl; Bob Lowenberg
Journal: Blood Date: 2007-01-09 Impact factor: 22.113

3. A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy.

Authors: Lisa Kottschade; Adam Brys; Tobias Peikert; Mabel Ryder; Laura Raffals; Jerry Brewer; Paul Mosca; Svetomir Markovic
Journal: Melanoma Res Date: 2016-10 Impact factor: 3.599

4. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.

Authors: S A Rosenberg; P Aebersold; K Cornetta; A Kasid; R A Morgan; R Moen; E M Karson; M T Lotze; J C Yang; S L Topalian
Journal: N Engl J Med Date: 1990-08-30 Impact factor: 91.245

Review 5. Immunotherapy Approaches in Cancer Treatment.

Authors: Pavel Klener; Pavel Otáhal; Lucie Lateckova; Pavel Klener
Journal: Curr Pharm Biotechnol Date: 2015 Impact factor: 2.837

6. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.

Authors: Stefan Suciu; Franco Mandelli; Theo de Witte; Robert Zittoun; Eugenio Gallo; Boris Labar; Gennaro De Rosa; Amine Belhabri; Rosario Giustolisi; Richard Delarue; Vincenzo Liso; Salvatore Mirto; Giuseppe Leone; Jean-Henri Bourhis; Giuseppe Fioritoni; Ulrich Jehn; Sergio Amadori; Paola Fazi; Anne Hagemeijer; Roel Willemze
Journal: Blood Date: 2003-04-24 Impact factor: 22.113

Review 7. Interleukin 2 in cancer therapy.

Authors: G K Antony; A Z Dudek
Journal: Curr Med Chem Date: 2010 Impact factor: 4.530

Review 8. Cancer immunotherapy: harnessing the immune system to battle cancer.

Authors: Yiping Yang
Journal: J Clin Invest Date: 2015-09-01 Impact factor: 14.808

9. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.

Authors: S A Rosenberg; J C Yang; S L Topalian; D J Schwartzentruber; J S Weber; D R Parkinson; C A Seipp; J H Einhorn; D E White
Journal: JAMA Date: 1994 Mar 23-30 Impact factor: 56.272

Review 10. New approaches for cancer immunotherapy.

Authors: Ayfer Karlitepe; Ozgun Ozalp; Cigir Biray Avci
Journal: Tumour Biol Date: 2015-05-02

26 in total

Review 1. The future of microfluidics in immune checkpoint blockade.

Authors: Jonathan Briones; Wilfred Espulgar; Shohei Koyama; Hyota Takamatsu; Eiichi Tamiya; Masato Saito
Journal: Cancer Gene Ther Date: 2020-10-27 Impact factor: 5.987

Review 2. Comprehensive comparison of theranostic nanoparticles in breast cancer.

Authors: Amin Nikdouz; Nima Namarvari; Ramin Ghasemi Shayan; Arezoo Hosseini
Journal: Am J Clin Exp Immunol Date: 2022-02-15

3. Gastrointestinal Toxicities of Immune Checkpoint Inhibitors Are Associated With Enhanced Tumor Responsiveness and Improved Survival.

Authors: Mohammad Alomari; Suleiman Al Ashi; Pravallika Chadalavada; Shrouq Khazaaleh; Fahrettin Covut; Laith Al Momani; Ahmed Elkafrawy; Vinay Padbidri; Pauline Funchain; Donald Campbell; Carlos Romero-Marrero
Journal: Gastroenterology Res Date: 2022-03-12

Review 4. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.

Authors: Kevin Dzobo; Dimakatso Alice Senthebane; Chelene Ganz; Nicholas Ekow Thomford; Ambroise Wonkam; Collet Dandara
Journal: Cells Date: 2020-08-13 Impact factor: 6.600

5. The promise of Immuno-oncology: implications for defining the value of cancer treatment.

Authors: Howard L Kaufman; Michael B Atkins; Prasun Subedi; James Wu; James Chambers; T Joseph Mattingly; Jonathan D Campbell; Jeff Allen; Andrea E Ferris; Richard L Schilsky; Daniel Danielson; J Leonard Lichtenfeld; Linda House; Wendy K D Selig
Journal: J Immunother Cancer Date: 2019-05-17 Impact factor: 13.751

Review 6. Adverse Events of Oncologic Immunotherapy and Their Management.

Authors: Fedricker Diane Barber
Journal: Asia Pac J Oncol Nurs Date: 2019 Jul-Sep

Review 7. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.

Authors: Laurel B Darragh; Ayman J Oweida; Sana D Karam
Journal: Front Immunol Date: 2019-01-31 Impact factor: 7.561

Review 8. Neutrophil Maturity in Cancer.

Authors: John B G Mackey; Seth B Coffelt; Leo M Carlin
Journal: Front Immunol Date: 2019-08-14 Impact factor: 7.561

Review 9. Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy.

Authors: Jia Zhuang; Maya Holay; Joon Ho Park; Ronnie H Fang; Jie Zhang; Liangfang Zhang
Journal: Theranostics Date: 2019-10-15 Impact factor: 11.556

10. Learning-accelerated discovery of immune-tumour interactions.

Authors: Jonathan Ozik; Nicholson Collier; Randy Heiland; Gary An; Paul Macklin
Journal: Mol Syst Des Eng Date: 2019-06-07